Asklepios BioPharmaceutical, Inc.
LEI: 52990041V02U4BTXDI11
Asklepios BioPharmaceutical, Inc.
en
c/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST
Wilmington, Delaware (US-DE), 19801
UNITED STATES
20 TW ALEXANDER DRIVE
DURHAM, Delaware (US-DE), 27709
UNITED STATES
UNITED STATES (US)
Delaware (US-DE)
(US-DE): Division of Corporations, Department of State (RA000602)
7360795
Corporation (XTIQ)
GENERAL
ACTIVE
2019-04-04 22:00:00
CHANGE_LEGAL_ADDRESS
2024-10-24 22:00:00
2024-10-25 08:38:14
SUPPORTING_DOCUMENTS
COMPLETED
2022-12-31 23:00:00
2023-12-30 23:00:00
ACCOUNTING_PERIOD
2020-12-09 23:00:00
RELATIONSHIP_PERIOD
2024-02-22 23:00:00
DOCUMENT_FILING_PERIOD
ACTIVE
2020-12-10 10:02:50
2024-10-25 08:38:14
PUBLISHED
FULLY_CORROBORATED
ACCOUNTS_FILING
2022-12-31 23:00:00
2023-12-30 23:00:00
ACCOUNTING_PERIOD
2020-12-09 23:00:00
RELATIONSHIP_PERIOD
2024-02-22 23:00:00
DOCUMENT_FILING_PERIOD
ACTIVE
2020-12-10 10:02:50
2024-10-25 08:38:15
PUBLISHED
FULLY_CORROBORATED
ACCOUNTS_FILING
2020-12-10 10:02:50
2024-10-25 08:38:14
2025-12-10 10:02:50
ISSUED
FULLY_CORROBORATED
(US-DE): Division of Corporations, Department of State (RA000602)
7360795